Questions with the most recent answer or edit.
Numbers first: REDEFINE-1 · hair thinning. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
The case in front of me: HJ · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I am working with: SURMOUNT-2 · 50 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline.…
I have been logging for eleven weeks and I do not trust my own log. I thought I was averaging 110 g of protein. Then I weighed everything for four days out of…
I received a printed notice stating that a parcel addressed to me was detained on import, describing the contents as an unapproved medicinal product, and giving me a…
What I have: mazdutide · SURPASS-2. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how confident…
This is my second independent submission on material from the same supplier. I would like to understand the steps well enough to explain them to someone else. I have…
Concretely: semaglutide · minus 80 °C · five days. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I…
Setup, so nobody has to ask: Xianning · Canada. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The case in front of me: survodutide · four weeks · room temperature. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months…
The case in front of me: a quantified content assay · tirzepatide. I would like the axes of comparison first and the recommendation second. I have tried the first…
I keep a written log of every draw with date, volume and syringe type. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may…
I have kept every message, invoice and document, which I gather is the useful habit. I have read the obvious sources and they disagree with each other, so I would…
The method section is present, which is unusual enough that I want to make use of it. These are treated as interchangeable and I do not think they are. If both are…
Conditions: ecnoglutide · PIONEER-1. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
I am comparing a supplier certificate against an independent result on the same lot. The failure mode I am trying to avoid is making this decision emotionally. I have…
Conditions: 2.5 mg · 0.5 mL · 0.9% sodium chloride · a GLP-1 receptor agonist. I want to decide this in advance so that I am not deciding it under pressure later.…
Concretely: semaglutide · a C4 column · survodutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I want to know whether this is a real physical effect or an artefact of…
I keep a written log of every draw with date, volume and syringe type. This should be a straightforward calculation and I keep getting two different answers. The…
Concretely: survodutide · 8 mg. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the…
Details up front: SURMOUNT-1 · dulaglutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
Conditions: survodutide · four weeks · 2–8 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question…
The particulars: 97.6% · survodutide. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator…